Table 2.
Use of medical or surgical therapy during the first two years since Crohn's disease diagnosis.
Overall patients | EO (≤17 years) | LO (≥60 years) | ||
---|---|---|---|---|
N = 160 | N = 92 | N = 68 | p | |
Corticosteroids | 89 (56%) | 61 (66%) | 28 (41%) | <0.005 |
Immunosuppressants | 37 (23%) | 25 (27%) | 12 (18%) | 0.2 |
Anti-TNF-α agents | 17 (11%) | 14 (15%) | 3 (4%) | 0.05 |
First surgery | 50 (31%) | 24 (26%) | 26 (38%) | 0.1 |
Second surgery | 5 (3%) | 3 (3%) | 2 (3%) | 0.9 |
TNF-α: tumour necrosis factor alpha.